141 related articles for article (PubMed ID: 12126746)
1. The mechanism of the angiotensin-converting enzyme inhibitor quinapril is not related to bradykinin level in heart tissue.
Barthelemy C; Eurin J; Lechat P; Masson F; Cortines M; Mougenot N; Soualmia H; Carayon A
Peptides; 2002 Jun; 23(6):1161-9. PubMed ID: 12126746
[TBL] [Abstract][Full Text] [Related]
2. Acute and long-term dose-response study of quinapril on hormonal profile and tissue angiotensin-converting enzyme in Wistar rats.
Schaison FH; Fernando Ramirez-Gil J; Ciferri S; Bernard M; Baudin B; Mougenot N; Carayon A; Lechat P
J Cardiovasc Pharmacol; 1996 Jul; 28(1):11-8. PubMed ID: 8797130
[TBL] [Abstract][Full Text] [Related]
3. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system.
Leenen FH; White R; Yuan B
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2410-6. PubMed ID: 11709406
[TBL] [Abstract][Full Text] [Related]
4. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects.
Pellacani A; Brunner HR; Nussberger J
Clin Sci (Lond); 1994 Nov; 87(5):567-74. PubMed ID: 7874846
[TBL] [Abstract][Full Text] [Related]
5. Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.
Endlich K; Steinhausen M
J Hypertens; 1997 Jun; 15(6):633-41. PubMed ID: 9218183
[TBL] [Abstract][Full Text] [Related]
6. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
[TBL] [Abstract][Full Text] [Related]
7. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
8. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
Keuneke C; Yacullo R; Metzger R; Hellmann T; Peters J; Ganten D
Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin-converting enzyme inhibitors on resistance artery structure and endothelium-dependent relaxation in two-kidney, one-clip Goldblatt hypertensive and sham-operated rats.
Bennett MA; Thurston H
Clin Sci (Lond); 1996 Jan; 90(1):21-9. PubMed ID: 8697701
[TBL] [Abstract][Full Text] [Related]
10. AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats.
Walther T; Siems WE; Hauke D; Spillmann F; Dendorfer A; Krause W; Schultheiss HP; Tschöpe C
FASEB J; 2002 Aug; 16(10):1237-41. PubMed ID: 12153991
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy.
Lear W; Ruzicka M; Leenen FH
Am J Physiol; 1997 Aug; 273(2 Pt 2):H641-6. PubMed ID: 9277479
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
Ma H; Hashizume H; Hara A; Yazawa K; Abiko Y
Jpn J Pharmacol; 1999 Jan; 79(1):17-24. PubMed ID: 10082313
[TBL] [Abstract][Full Text] [Related]
13. Preservation of left ventricular mechanical function and energy metabolism in rats after myocardial infarction by the angiotensin-converting enzyme inhibitor quinapril.
Horn M; Neubauer S; Frantz S; Hugel S; Hu K; Gaudron P; Schnackerz K; Ertl G
J Cardiovasc Pharmacol; 1996 Feb; 27(2):201-10. PubMed ID: 8720418
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans.
Kim KS; Kumar S; Simmons WH; Brown NJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):295-8. PubMed ID: 10604961
[TBL] [Abstract][Full Text] [Related]
15. Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors.
Leenen FH; Skarda V; Yuan B; White R
Am J Physiol; 1999 Jan; 276(1):H317-25. PubMed ID: 9887046
[TBL] [Abstract][Full Text] [Related]
16. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
Brown NJ; Agirbasli M; Vaughan DE
Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
[TBL] [Abstract][Full Text] [Related]
17. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats.
Ruzicka M; Skarda V; Leenen FH
Circulation; 1995 Dec; 92(12):3568-73. PubMed ID: 8521580
[TBL] [Abstract][Full Text] [Related]
18. Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats.
Graziano MJ; Dethloff LA; Griffin HE; Pegg DG
Arch Int Pharmacodyn Ther; 1993; 324():87-104. PubMed ID: 8297189
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
Sedman AJ; Posvar E
Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissue.
Fabris B; Chen BZ; Pupic V; Perich R; Johnston CI
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S6-13. PubMed ID: 1691409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
